Physician profile
Robert Williams
NPI 1144269697
$28,983.08
in general payments reported to CMS, 2019-2025
22 companies · $1,502 in 2025
The $1,502 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,446 · 2020: $549 · 2021: $8,182 · 2022: $2,954 · 2023: $612 · 2024: $11K · 2025: $1,502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,600 · Food and Beverage: $2,715 · Travel and Lodging: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,600.00 |
| Food and Beverage | $2,715.11 |
| Travel and Lodging | $536.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $24,559.35 | 2019-2025 | Titan, Virtue |
| Boston Scientific Corporation | $1,615.34 | 2019-2024 | Spaceoar Vue System - 10ml |
| Lina Medical USA INC | $895.34 | 2022 | |
| Abbvie INC. | $636.92 | 2019-2025 | Botox, Lupron Depot |
| Astellas Pharma US INC | $307.09 | 2019-2024 | Myrbetriq |
| Femselect INC. | $164.40 | 2022-2025 | Enplace |
| Medtronic USA, INC. | $133.45 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $107.42 | 2023 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $89.01 | 2019-2022 | |
| Urovant Sciences INC | $79.47 | 2021-2022 | |
| Allergan, INC. | $72.89 | 2019-2022 | |
| Teleflex LLC | $53.75 | 2023-2024 | Urolift |
| Ferring Pharmaceuticals INC. | $42.57 | 2024-2025 | Adstiladrin |
| Myovant Sciences INC. | $37.72 | 2021-2022 | |
| Healthtronics Stone Solutions, LLC | $37.28 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $27.94 | 2020 | |
| Tolmar Pharmaceuticals, INC. | $25.45 | 2019 | |
| Sun Pharmaceutical Industries INC. | $22.66 | 2022 | |
| Laborie Medical Technologies Corp. | $22.10 | 2022 | |
| Axonics, INC. | $19.01 | 2022 | |
| Urogen Pharma, INC. | $17.02 | 2023 | Jelmyto |
| Blue Earth Diagnostics | $16.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.